State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK).

When disease travels downstream: The effect of intravesical recurrences in patients treated for upper tract urothelial carcinoma.

Retroperitoneal lymph-node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series.

Early penile prosthesis infections in the contemporary antimicrobial era: Incidence and predictive factors from a regional cohort.

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort.

1H MR\u2010based detection of human plasma metabolic alterations in clear cell renal cell carcinoma

State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK).

When disease travels downstream: The effect of intravesical recurrences in patients treated for upper tract urothelial carcinoma.

Retroperitoneal lymph-node dissection for isolated nodal recurrence of renal cell carcinoma after nephrectomy: Contemporary outcomes of a case series.

Early penile prosthesis infections in the contemporary antimicrobial era: Incidence and predictive factors from a regional cohort.

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort.

1H MR\u2010based detection of human plasma metabolic alterations in clear cell renal cell carcinoma